Last reviewed · How we verify
oxaliplatin, gemcitabine, bevacizumab
oxaliplatin, gemcitabine, bevacizumab is a Small molecule drug developed by Mt. Sinai Medical Center, Miami. It is currently in Phase 2 development.
At a glance
| Generic name | oxaliplatin, gemcitabine, bevacizumab |
|---|---|
| Sponsor | Mt. Sinai Medical Center, Miami |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer (NA)
- SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety (PHASE2)
- A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. (PHASE1)
- A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. (PHASE1)
- Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA (PHASE2)
- A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) (PHASE1, PHASE2)
- Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer (PHASE3)
- A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- oxaliplatin, gemcitabine, bevacizumab CI brief — competitive landscape report
- oxaliplatin, gemcitabine, bevacizumab updates RSS · CI watch RSS
- Mt. Sinai Medical Center, Miami portfolio CI
Frequently asked questions about oxaliplatin, gemcitabine, bevacizumab
What is oxaliplatin, gemcitabine, bevacizumab?
oxaliplatin, gemcitabine, bevacizumab is a Small molecule drug developed by Mt. Sinai Medical Center, Miami.
Who makes oxaliplatin, gemcitabine, bevacizumab?
oxaliplatin, gemcitabine, bevacizumab is developed by Mt. Sinai Medical Center, Miami (see full Mt. Sinai Medical Center, Miami pipeline at /company/mt-sinai-medical-center-miami).
What development phase is oxaliplatin, gemcitabine, bevacizumab in?
oxaliplatin, gemcitabine, bevacizumab is in Phase 2.